Investor Presentaiton
Key Balance sheet Items
All values in Mn
Particulars
Mar-23*
Dec-22*
Mar-22"
Shareholders Funds
6,981
7,715
6,919
Minority Interest
500
482
480
Net Debt
3,561
3,631
2,542
Investments
0
0
368
Tangible Assets
3,622
3,780
3,263
Intangible Assets
3,085
3,186
2,498
Working Capital
4,261
4,804
4,222
Put/Buyout Liabilities
^159
J Sequent
Proven Ability In Life Sciences
ALIVIRA
Balance Sheet Highlights
ā Operational initiatives - working capital days
reduced by 11 days
ā Net Debt is marginally down
*Mar'23 & Dec'22 reported numbers are adjusted for impact of hyperinflation accounting in Turkey as per IndAS 29 - 'Accounting for Hyperinflationary economies'
^ Buyout Liabilities of 159 Mn in Mar'22 paid on account of Nourrie acquisition
`Mar'22 restated on account of Nourrie amalgamation
11View entire presentation